NRAS and melanoma: Mutations in genes involved in the MAPK pathway are most common in melanoma with changes in mitochondrial function, including activating mutations in the BRAF gene, NRAS gene and tyrosine kinase (such as KIT) and inactivating mutation in the NF1 gene [167–170].